⌘K

Login Start Free

Home/Filings/4/0001628280-24-044663

4//SEC Filing

ACKERMAN JOEL 4

Accession 0001628280-24-044663

CIK 0000771856other

View on SEC.gov Company Profile

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 9:04 AM ET

Size

10.6 KB

Accession

0001628280-24-044663

Insider Transaction Report

Form 4

Period: 2024-10-31

CHAMPIONS ONCOLOGY, INC.CSBR

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2024-10-31$2.10/sh+88,470$185,787→ 945,467 total
Exercise/Conversion
Common Stock
2024-10-31$5.43/sh+16,667$90,502→ 962,134 total
Exercise/Conversion
Option to purchase Common Stock
2024-10-31$2.10/sh−88,470$185,787→ 0 total
Exercise: $2.10Exp: 2024-11-01→ Common Stock (88,470 underlying)
Exercise/Conversion
Option to purchase Common Stock
2024-10-31$5.43/sh−16,667$90,502→ 0 total
Exercise: $5.43Exp: 2024-11-03→ Common Stock (16,667 underlying)

Footnotes (2)

[F1]The options were immediately exercisable upon grant on July 19, 2016.
[F2]4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on February 4, 2020, May 4, 2020 and August 4, 2020.

Documents

1 file

4
wk-form4_1730466270.xmlPrimary
FORM 4

Issuer

CHAMPIONS ONCOLOGY, INC.

CIK 0000771856

Entity typeother

Related Parties

1

filerCIK 0001220630

Filing Metadata

Form type: 4
Filed: Oct 31, 8:00 PM ET
Accepted: Nov 1, 9:04 AM ET
Size: 10.6 KB

View on SEC.gov